A New Route to Substituted Pyrimido[5,4-e]-1,2,4-triazine-5,7(1H,6H)-diones and
Facile Extension to 5,7(6H,8H) Isomers

Anjanette J. Turbiak; H. D. Hollis Showalter

doi:10.1055/s-0029-1217030

PAPER

A New Route to Substituted Pyrimido[5,4-e]-1,2,4-triazine-5,7(1H,6H)-diones and Facile Extension to 5,7(6H,8H) Isomers

Anjanette J. Turbiak, H. D. Hollis Showalter*
Department of Medicinal Chemistry, University of Michigan, Ann Arbor, MI 48109-1065, USA
Fax: +1(734)6478430; e-Mail: showalh@umich.edu;

Abstract

Alle Artikel dieser Rubrik

Abstract

A new route to substituted pyrimido[5,4-e]-1,2,4-triazine-5,7(1H,6H)-diones is outlined. The synthesis proceeds via preformed hydrazone intermediates, which are then condensed with an activated chlorouracil to build up the entire molecular framework, followed by a reductive ring closure to provide the parent series. The route has been extended to the isomeric pyrimido[5,4-e]-1,2,4-triazine-5,7(6H,8H)-dione class via the use of methylhydrazine as hydrazine surrogate, followed by regiospecific alkylation of the N ⁸-H pyrimidotriazinediones with a range of alkyl and alkaryl substituents. This new methodology permits the generation of a wide range of compounds with variable substitution at the N^¹, C^³, and N⁸ positions for a heterocyclic scaffold with demonstrated pharmacological activity.

Key words

pyrimido[5,4-e]-1,2,4-triazine-5,7(1H,6H)-diones - pyrimido[5,4-e]-1,2,4-triazine-5,7(6H,8H)-diones - heterocycles - hydrazones - cyclizations

Volltext

Referenzen

References

<A NAME="RM02809SS-1A">1a</A> Lacrampe JFA, Connors RW, Ho CY, Richardson A, Freyne EJE, Buijnsters PJJ, and Bakker AC. inventors; WO 2004,007,498.

<A NAME="RM02809SS-1B">1b</A> Nagamatsu T. Yamasaki H. Hirota T. Yamato M. Kido Y. Shibata M. Yoneda F. Chem. Pharm. Bull. 1993, 41: 362

<A NAME="RM02809SS-1C">1c</A> Liao T. Baiocchi F. Cheng CC. J. Org. Chem. 1966, 31: 900

<A NAME="RM02809SS-1D">1d</A> Levenberg B. Linton SN. J. Biol. Chem. 1966, 241: 846

<A NAME="RM02809SS-2">2</A> Nagamatsu T. Yamasaki H. Yoneda F. Heterocycles 1994, 37: 1147

<A NAME="RM02809SS-3">3</A> Turbiak AJ. Showalter HDH. Tetrahedron Lett. 2009, 50: 1996

<A NAME="RM02809SS-4">4</A> Black HT. J. Heterocycl. Chem. 1987, 24: 1373

<A NAME="RM02809SS-5A">5a</A> Nagamatsu T. Yamasaki H. Hirota T. Yamato M. Kido Y. Shibata M. Yoneda F. Chem. Pharm. Bull. 1993, 41: 362

<A NAME="RM02809SS-5B">5b</A> Yoneda F. Nagamatsu T. Chem. Pharm. Bull. 1975, 23: 2001

<A NAME="RM02809SS-5C">5c</A> Yoneda F. Nagamatsu T. Shinomura K. J. Chem. Soc., Perkin Trans. 1 1976, 713

<A NAME="RM02809SS-6A">6a</A> Nagamatsu T. Yamasaki H. J. Chem. Soc., Perkin Trans. 1 2001, 130

<A NAME="RM02809SS-6B">6b</A> Yoneda F. Nagamatsu T. J. Heterocycl. Chem. 1974, 11: 271

<A NAME="RM02809SS-6C">6c</A> Yoneda F. Nagamatsu T. Tetrahedron Lett. 1973, 14: 1577

<A NAME="RM02809SS-7">7</A> Dabideen DR. Cheng KF. Aljabari B. Miller EJ. Pavlov VA. Al-Abed Y. J. Med. Chem. 2007, 50: 1993

<A NAME="RM02809SS-8">8</A> Yao HC. Resnick P. J. Org. Chem. 1965, 30: 2832

<A NAME="RM02809SS-9">9</A> Deng X. Mani NS. J. Org. Chem. 2008, 73: 2412

<A NAME="RM02809SS-10">10</A> Yoneda F. Nagamatsu T. Synthesis 1975, 177

<A NAME="RM02809SS-11">11</A> Yoneda F. Higuchi M. Nitta Y. J. Heterocycl. Chem. 1980, 17: 869

<A NAME="RM02809SS-12">12</A> Yoneda F. Nagamatsu T. J. Heterocycl. Chem. 1974, 11: 271